by healthadvances Posted on February 15, 2022 Women’s Health at Home: Reflections on a Rapidly Growing Space Read More
by healthadvances Posted on October 8, 2021 Building and Defending Markets; Reflections on Attending DTx and NASS Conferences Read More
by healthadvances Posted on October 1, 2021October 1, 2021 Resurgence in Drug Development for Renal Diseases Read More
by healthadvances Posted on September 29, 2021October 1, 2021 AI in Healthcare: Insights from Two Decades of FDA Approvals Read More
by healthadvances Posted on August 6, 2021August 9, 2021 Evidence Generation Strategy under Germany’s Digital Healthcare: Is More Better? Read More
by healthadvances Posted on July 21, 2021 India, the Generic Manufacturing Powerhouse, Biosimilar Next? Read More
by healthadvances Posted on June 30, 2021 Tencent-Backed Wedoctor Is Going Public: What Are the Next Steps for Chinese Digital Health Companies? Read More
by healthadvances Posted on January 15, 2021 Google Has Officially Acquired Fitbit. Now What? Read More
by healthadvances Posted on September 24, 2020October 22, 2020 When Off-Label is Your Biggest Competition: Rituximab in Autoimmune Diseases Read More
by healthadvances Posted on September 18, 2020 How COVID-19 Testing Demand Threw off Thermo Fisher’s Acquisition of Qiagen Read More
by healthadvances Posted on September 15, 2020 Hong Kong Exchange: Nurturing China’s Biotech Valley Read More
by healthadvances Posted on August 26, 2020August 26, 2020 eBook: Biopharma in the COVID-19 World Read More
by healthadvances Posted on August 17, 2020 Against All Odds: Can Covid-19 Usher in a New Era in International Public Health Cooperation? Read More
by healthadvances Posted on July 30, 2020January 13, 2021 Value Creation in Molecular Diagnostics: A Game of Luck or Skill? Read More
by healthadvances Posted on July 16, 2020July 17, 2020 Is Cardiovascular R&D Ready for a Comeback? Read More
by healthadvances Posted on July 16, 2020July 11, 2022 Demystifying SARS-CoV-2 Testing for COVID-19 (Third Edition: Updates and Trends) Read More
by healthadvances Posted on June 4, 2020 SARS-CoV-2 Landscape of Repurposed Drug Trials and Key Lessons for the Future Read More
by healthadvances Posted on May 14, 2020May 14, 2020 COVID-19 Impact on Rare Disease Patients and Manufacturers Read More
